Kim Chul, Cashdollar Michael R, Mendicino Robert W, Catanzariti Alan R, Fuge LaDonna
Department of Foot & Ankle Surgery, The Western Pennsylvania Hospital, Pittsburgh, Pennsylvania 15224, USA.
Foot Ankle Spec. 2010 Dec;3(6):335-7. doi: 10.1177/1938640010378530. Epub 2010 Sep 3.
Plantar fasciitis is commonly treated with corticosteroid injections to decrease pain and inflammation. Therapeutic benefits often vary in terms of efficacy and duration. Rupture of the plantar fascia has been reported as a possible complication following corticosteroid injection. A retrospective chart review of 120 patients who received corticosteroid injection for plantar fasciitis was performed at the authors' institution to determine the incidence of plantar fascia rupture. The plantar fascia rupture was diagnosed clinically and confirmed with magnetic resonance imaging. Various factors were analyzed, including the number of injections, interval between injections, body mass index (BMI), and activity level. Four patients (2.4%) consequently experienced plantar fascia rupture following an average of 2.67 injections. The average BMI of these patients was 38.6 kg/m². The authors conclude that corticosteroid injection therapy appears to be a safe and effective form of nonoperative treatment with minimal complications and a relatively low incident of plantar fascia rupture.
足底筋膜炎通常采用皮质类固醇注射治疗以减轻疼痛和炎症。治疗效果在疗效和持续时间方面往往有所不同。据报道,皮质类固醇注射后可能会出现足底筋膜破裂这一并发症。作者所在机构对120例接受皮质类固醇注射治疗足底筋膜炎的患者进行了回顾性病历审查,以确定足底筋膜破裂的发生率。足底筋膜破裂通过临床诊断,并经磁共振成像确认。分析了各种因素,包括注射次数、注射间隔、体重指数(BMI)和活动水平。4例患者(2.4%)在平均接受2.67次注射后发生了足底筋膜破裂。这些患者的平均BMI为38.6kg/m²。作者得出结论,皮质类固醇注射疗法似乎是一种安全有效的非手术治疗方式,并发症极少,足底筋膜破裂的发生率相对较低。